NCT06394700

Brief Summary

The goal of this study is to use a pilot RCT to assess the effectiveness of Written Exposure Therapy (WET) and a mindfulness-based app (MBA) for managing PTSD and comorbid insomnia in China. The main questions it aims to answer are:

  • Undergo random assignment to one of three groups: WET, WET plus MBA, or MCC.
  • Receive clinical interviews for primary outcomes (PTSD symptoms) at baseline, posttreatment, and during follow-ups.
  • Provide self-reported data on PTSD symptoms and insomnia severity at multiple time points.
  • In the WET plus MBA group, additionally use a mindfulness-based app as part of their treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

April 23, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

2.5 years

First QC Date

April 23, 2024

Last Update Submit

April 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • PTSD symptom severity

    The reduction in PTSD symptoms will be measured using the PTSD Symptom Scale, Interview Version for DSM-5 (PSSI-5). This clinician-administered interview assesses the frequency and severity of PTSD symptoms using a 5-point Likert scale ranging from 0 (not at all) to 4 (very much).

    Assessed at baseline, immediately post-treatment, and at 3-month follow-up periods.

Secondary Outcomes (1)

  • Insomnia Severity

    Insomnia severity is assessed at baseline, weekly during the 5-week treatment period, and at the immediate post-treatment, and 3-month follow-up assessments.

Study Arms (3)

Written Exposure Therapy (WET)

EXPERIMENTAL
Behavioral: written exposure therapy

Written Exposure Therapy plus mindfulness-based App (WET+MBA)

EXPERIMENTAL
Behavioral: Written Exposure Therapy plus Mindfulness-Based App (WET + MBA)

Minimal Contact Control (MCC)

PLACEBO COMPARATOR
Behavioral: Minimal Contact Control (MCC)

Interventions

Written Exposure Therapy (WET) is a manualized exposure-based therapy involving five sequential weekly individual sessions. Each session lasts approximately 40 minutes except the first, which is one hour. In the initial session, the therapist explains the treatment rationale and guides the participant to write about their traumatic experience uninterrupted for 30 minutes. Subsequent sessions start with a brief discussion about the previous session's writing, followed by another 30-minute writing session, concluding with a short check-in. There is no homework between sessions.

Written Exposure Therapy (WET)

WET + MBA combines the standard WET protocol with the addition of a mindfulness practice facilitated through a mobile app called "Now Meditation." This app is among the most downloaded mindfulness apps in China, used to help manage symptoms of insomnia commonly comorbid with PTSD. Participants are instructed to engage in daily mindfulness exercises according to the app's "7-Day Basic Meditation" program and continue practicing mindfulness throughout the duration of the therapy. This is intended to supplement the therapeutic effects of WET by providing tools to manage insomnia and potentially enhancing the therapeutic process by fostering greater mindfulness and relaxation.

Written Exposure Therapy plus mindfulness-based App (WET+MBA)

MCC contains weekly phone calls from a study therapist to monitor their status and provide support as needed, without introducing any specific therapeutic interventions. These calls are brief, generally lasting between 10 to 15 minutes, and are strictly for the purpose of engagement and safety monitoring rather than therapeutic intervention.

Minimal Contact Control (MCC)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult male and female aged between 18-65 years old;
  • A diagnosis of PTSD or subthreshold PTSD (PTSD Symptom Scale, Interview Version for DSM-5, PSSI-5);
  • If currently taking psychotropic medication, taking a stable one for at least 4 weeks;
  • A smartphone owner and no obstacle to the Now Meditation App;
  • Scoring 12 or more on Insomnia Severity Index (ISI; the symptoms appear after the diagnosis of full/subthreshold PTSD).

You may not qualify if:

  • A diagnosis of bipolar disorder or psychotic disorder;
  • Current substance dependence;
  • Evidence of a moderate or severe traumatic brain injury (as determined by the obstacle to comprehending the baseline screening questionnaires);
  • Serious suicidal ideation (as determined by the Scale for Suicidal Ideation);
  • Other psychiatric disorders severe enough to warrant designation as the primary disorder;
  • Taking psychotherapy for PTSD currently.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University

Beijing, Beijing Municipality, 100871, China

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSleep Initiation and Maintenance Disorders

Interventions

Wettability

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Hydrophobic and Hydrophilic InteractionsChemical PhenomenaSurface Properties

Central Study Contacts

Yinyin Zang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 23, 2024

First Posted

May 1, 2024

Study Start

November 11, 2021

Primary Completion

May 1, 2024

Study Completion

August 1, 2024

Last Updated

May 1, 2024

Record last verified: 2024-04

Locations